Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 126978881 | 12697888 | 1 | I | 20160826 | 20160830 | 20160830 | PER | US-PFIZER INC-2016407899 | PFIZER | 71.00 | YR | F | Y | 0.00000 | 20160830 | MD | US | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 126978881 | 12697888 | 1 | PS | EXEMESTANE. | EXEMESTANE | 1 | UNK | 20753 | |||||||||||
| 126978881 | 12697888 | 2 | SS | EXEMESTANE. | EXEMESTANE | 1 | 20753 | ||||||||||||
| 126978881 | 12697888 | 3 | SS | FULVESTRANT | FULVESTRANT | 1 | UNK | 0 | |||||||||||
| 126978881 | 12697888 | 4 | SS | FULVESTRANT | FULVESTRANT | 1 | 0 | ||||||||||||
| 126978881 | 12697888 | 5 | SS | LETROZOLE. | LETROZOLE | 1 | UNK | 0 | |||||||||||
| 126978881 | 12697888 | 6 | SS | LETROZOLE. | LETROZOLE | 1 | 0 | ||||||||||||
| 126978881 | 12697888 | 7 | SS | XELODA | CAPECITABINE | 1 | UNK | 0 | |||||||||||
| 126978881 | 12697888 | 8 | SS | XELODA | CAPECITABINE | 1 | 0 | ||||||||||||
| 126978881 | 12697888 | 9 | SS | EVEROLIMUS | EVEROLIMUS | 1 | UNK | 0 | |||||||||||
| 126978881 | 12697888 | 10 | SS | EVEROLIMUS | EVEROLIMUS | 1 | 0 | ||||||||||||
| 126978881 | 12697888 | 11 | SS | TAXOL | PACLITAXEL | 1 | UNK UNK, WEEKLY | 0 | /wk | ||||||||||
| 126978881 | 12697888 | 12 | SS | TAXOL | PACLITAXEL | 1 | 0 | ||||||||||||
| 126978881 | 12697888 | 13 | SS | DOXIL | DOXORUBICIN HYDROCHLORIDE | 1 | UNK | 0 | |||||||||||
| 126978881 | 12697888 | 14 | SS | DOXIL | DOXORUBICIN HYDROCHLORIDE | 1 | 0 | ||||||||||||
| 126978881 | 12697888 | 15 | SS | ERIBULIN | ERIBULIN | 1 | UNK | 0 | |||||||||||
| 126978881 | 12697888 | 16 | SS | ERIBULIN | ERIBULIN | 1 | 0 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 126978881 | 12697888 | 1 | Breast cancer |
| 126978881 | 12697888 | 2 | Breast cancer metastatic |
| 126978881 | 12697888 | 3 | Breast cancer |
| 126978881 | 12697888 | 4 | Breast cancer metastatic |
| 126978881 | 12697888 | 5 | Breast cancer |
| 126978881 | 12697888 | 6 | Breast cancer metastatic |
| 126978881 | 12697888 | 7 | Breast cancer |
| 126978881 | 12697888 | 8 | Breast cancer metastatic |
| 126978881 | 12697888 | 9 | Breast cancer |
| 126978881 | 12697888 | 10 | Breast cancer metastatic |
| 126978881 | 12697888 | 11 | Breast cancer |
| 126978881 | 12697888 | 12 | Breast cancer metastatic |
| 126978881 | 12697888 | 13 | Breast cancer |
| 126978881 | 12697888 | 14 | Breast cancer metastatic |
| 126978881 | 12697888 | 15 | Breast cancer |
| 126978881 | 12697888 | 16 | Breast cancer metastatic |
Outcome of event
| no results found |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 126978881 | 12697888 | Breast cancer metastatic | |
| 126978881 | 12697888 | Disease progression |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 126978881 | 12697888 | 1 | 20140810 | 20150727 | 0 | |
| 126978881 | 12697888 | 3 | 20101229 | 20130401 | 0 | |
| 126978881 | 12697888 | 5 | 20130429 | 20131111 | 0 | |
| 126978881 | 12697888 | 7 | 20131225 | 201408 | 0 | |
| 126978881 | 12697888 | 9 | 20140810 | 20150727 | 0 | |
| 126978881 | 12697888 | 11 | 20150810 | 20151116 | 0 | |
| 126978881 | 12697888 | 13 | 20151209 | 20160204 | 0 | |
| 126978881 | 12697888 | 15 | 20160310 | 20160602 | 0 |